Loading company…
SK Plasma produces medicines derived from human blood plasma.
Founded in 2015 and based in Seongnam, South Korea, SK Plasma develops plasma-derived medicines. Its products include immunoglobulins, hepatitis B antibodies, human serum albumin, antithrombin III, and tetanus immunoglobulin. A fractionation plant was completed in Andong in 2016, and commercial production began in August 2018 after KGMP approval.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in